PharmaXportsTrusted Medicines. Healthier Tomorrow.
Tier 2 — Semi-regulated

Pharma Export to CIS & Russia from India

India has a long-established generics presence across the CIS region. Roszdravnadzor (Russia) and equivalent national regulators generally accept a WHO-GMP + COPP dossier, with local registration (GOST standards) required per country.

Countries: Russia

What Sells in This Market

Broad genericsOTC formulationsCardiovascular and CNS medicines

Regulatory Pathway

Pathway

Roszdravnadzor (Russia) and equivalent national regulators across the CIS.

Plant Requirement

WHO-GMP + COPP usually accepted; local registration to GOST standards required.

Timeline

12–36 months per product

Barrier to Entry

Medium

Regulatory Considerations

  • Local registration to GOST standards is required per country
  • Established Indian generic brands already compete in this corridor, so differentiation on category or documentation quality matters

Documentation

  • Commercial invoice
  • Packing list
  • Certificate of Origin
  • Certificate of Analysis
  • Certificate of Pharmaceutical Product (COPP)
  • GMP certificate
  • Import permit of the buyer

Market Opportunity

A semi-regulated corridor with an established Indian generics presence, realistic for year two or three of an export programme.

Frequently Asked Questions

Yes — India has a long-established generics presence across the CIS region, though local GOST registration and a semi-regulated timeline (12–36 months per product) still apply.

Typical Buyer Types

  • Licensed importers and distributors
  • Wholesale pharmacy chains
Requirements vary by product and destination. This page describes the general market landscape, not company-specific sales coverage or a guarantee of registration outcome.
Request a Quote for CIS & Russia

Related Products for This Market

Ready to Source for CIS & Russia?

Get an Export QuoteView Compliance Framework
Get a Quote